Tag Archives: Drug-resistant TB
New Delhi: The Indian Council of Medical Research (ICMR) is planning to test the efficacy of two medicines — Metformin and Bedaquiline Delaminate — for tackling the drug-resistant tuberculosis.
New Delhi: Indian Spinal Injuries Centre treated an unusual case of a banker diagnosed with tuberculosis which subsequently spread to her bones making her limp with pain that was getting progressively worse.
Geneva: Outdated tuberculosis (TB) policies and practices are risking the further spread of drug-resistant TB globally, warns a 24-country survey, urging a phase-out of mandatory hospitalisation and re-treatment regimens that contribute to drug resistance.
New York: Prescribing antibiotic doses once or twice a week for tuberculosis (TB) treatment are more likely to lead to drug resistant strains than daily antibiotic regimens, new research has found.
Washington: Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health. The study is published in PLOS ONE.
New Delhi: Large-scale study results published in PLoS One show that the use of Xpert MTB/RIF as the initial test for tuberculosis (TB) in public health facilities in India significantly increases the number of TB cases detected and notified.
Washington: Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. They describe their findings in a paper published in Bioorganic and Medicinal Chemistry Letters.
Washington: St Jude Children’s Research Hospital scientists have discovered a promising new class of antibiotics that could aid efforts to overcome drug-resistance in tuberculosis (TB). The drugs increased survival of mice infected with TB and were effective against drug-resistant strains of TB. St Jude led the international research effort, results of which appear in the journal Nature Medicine.
Washington: In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study is published in Nature Communications.
Berlin: A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO (European Molecular Biology Organization) Molecular Medicine.